Managing tuberculosis in patients with diabetes mellitus: why we care and what we know

被引:0
作者
Jeon, Christie Y. [1 ]
Murray, Megan B. [2 ,3 ]
Baker, Meghan A. [4 ,5 ,6 ]
机构
[1] Columbia Univ, Sch Nursing, New York, NY 10032 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA
[4] Harvard Univ, Dept Populat Med, Sch Med, Boston, MA USA
[5] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[6] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA
关键词
antibiotic treatment; diabetes mellitus; glucose control; tuberculosis; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; PHARMACOKINETICS; PREVALENCE; RISK; MICE; SUSCEPTIBILITY; CONVERGENCE; EPIDEMICS; INFECTION;
D O I
10.1586/ERI.12.75
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
As the global prevalence of diabetes mellitus (DM) increases, especially in low-to-middle income countries where tuberculosis (TB) remains endemic, we will encounter a growing number of TB patients with DM. This is a major concern for TB control programs, clinicians and patients alike because DM patients are at an increased risk of TB and are more likely to face poor TB treatment outcomes, including treatment failure, relapse and even death. Priority should be placed on early detection of both diseases through active screening, monitoring of adherence to medications for both diseases, and integration of TB and DM management strategies that would facilitate the provision of more comprehensive services that TB patients with DM require.
引用
收藏
页码:863 / 868
页数:6
相关论文
共 44 条
[31]   INFECTION AND DIABETES - THE CASE FOR GLUCOSE CONTROL [J].
RAYFIELD, EJ ;
AULT, MJ ;
KEUSCH, GT ;
BROTHERS, MJ ;
NECHEMIAS, C ;
SMITH, H .
AMERICAN JOURNAL OF MEDICINE, 1982, 72 (03) :439-450
[32]   Convergence of the tuberculosis and diabetes epidemics: Renewal of old acquaintances [J].
Restrepo, Blanca I. .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (04) :436-438
[33]  
Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352
[34]   Sputum smear conversion during directly observed treatment for tuberculosis [J].
Rieder, HL .
TUBERCLE AND LUNG DISEASE, 1996, 77 (02) :124-129
[35]   Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes [J].
Ruslami, Rovina ;
Nijland, Hanneke M. J. ;
Adhiarta, I. Gusti N. ;
Kariadi, H. K. S. ;
Alisjahbana, Bachti ;
Aarnoutse, Rob E. ;
van Crevel, Reinout .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) :1068-1074
[36]   DEPRESSED IMMUNOLOGICAL DEFENSE-MECHANISMS IN MICE WITH EXPERIMENTALLY INDUCED DIABETES [J].
SAIKI, O ;
NEGORO, S ;
TSUYUGUCHI, I ;
YAMAMURA, Y .
INFECTION AND IMMUNITY, 1980, 28 (01) :127-131
[37]   Pulmonary tuberculosis in spontaneously diabetic Goto Kakizaki rats [J].
Sugawara, I ;
Yamada, H ;
Mizuno, S .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 204 (02) :135-145
[38]   Higher Susceptibility of Type 1 Diabetic Rats to Mycobacterium tuberculosis Infection [J].
Sugawara, Isamu ;
Mizuno, Satoru .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 216 (04) :363-370
[39]   Diabetic Mice Display a Delayed Adaptive Immune Response to Mycobacterium tuberculosis [J].
Vallerskog, Therese ;
Martens, Gregory W. ;
Kornfeld, Hardy .
JOURNAL OF IMMUNOLOGY, 2010, 184 (11) :6275-6282
[40]   Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis [J].
Wang, C. S. ;
Yang, C. J. ;
Chen, H. C. ;
Chuang, S. H. ;
Chong, I. W. ;
Hwang, J. J. ;
Huang, M. S. .
EPIDEMIOLOGY AND INFECTION, 2009, 137 (02) :203-210